QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:April 5, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:April 5, 2022Withdrawn
Condition(s):TNBC – Triple-Negative Breast Cancer; Minimal Residual DiseaseLast Updated:January 30, 2024Recruiting
Condition(s):Advanced Triple Negative Breast Cancer (TNBC) With High TAMsLast Updated:June 21, 2021Completed
Condition(s):ER-Negative PR-Negative HER2-Negative Breast CancerLast Updated:May 15, 2023Completed
Condition(s):Triple Negative Breast Cancer; Triple Negative Breast NeoplasmsLast Updated:March 4, 2024Recruiting
Condition(s):Breast Cancer Triple NegativeLast Updated:January 31, 2024Not yet recruiting
Condition(s):Triple Negative Breast Cancer (TNBC)Last Updated:March 5, 2024Recruiting
Condition(s):Breast Cancer FemaleLast Updated:January 8, 2024Not yet recruiting
Condition(s):Breast CancerLast Updated:April 22, 2022Completed
Condition(s):Breast CancerLast Updated:April 20, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.